USPTO serial 79461504
TELUM THERAPEUTICS
Reviewed by CopyMark Law Group
Status 640Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- KHAN, AHSEN M
- Law office
- TMO LAW OFFICE 113
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with TELUM THERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic products for scientific use; reagents for medical research; Reagents for medical research in the field of infectious diseases and diseases caused by bacteria; diagnostic reagents for scientific use or for research; Enzymes for scientific use; diagnostic kits for scientific use comprising specimen receptacles and reagents for analyzing selected bacteria. | ACTIVE | — |
| 005 | Pharmaceutical products for infectious disease treatment; pharmaceutical products for treatment of diseases caused by bacteria; Antibacterial pharmaceutical products; antibiotics; Biopharmaceuticals for infectious disease treatment; immunotherapeutic agents for bacterial infections; Enzyme preparations for medical use; enzymes for medical use; Enzymes and enzyme preparations for diagnosis, prognosis and treatment of infectious diseases and diseases caused by bacteria; tests, biomarkers and reagents for diagnosis, prognosis and treatment of infectious diseases and diseases caused by bacteria. | ACTIVE | — |
| 042 | Biomedical research services; scientific research for medical purposes in the field of infectious diseases and diseases caused by bacteria; Research and development of pharmaceutical products, antibiotics, tests, biomarkers and reagents for diagnosis, prognosis and treatment of infectious diseases and diseases caused by bacteria; research and development of immunotherapeutic agents for bacterial infections; Research and development of enzymes, enzyme preparations and synthetic proteins for diagnosis, prognosis and treatment of infectious diseases and diseases caused by bacteria; clinical trials for pharmaceutical products, antibiotics, tests, biomarkers and reagents for diagnosis, prognosis and treatment of infectious diseases and diseases caused by bacteria; Software as a Service [SaaS]; Platform as a Service [PaaS]; Artificial Intelligence as a Service [AIaaS]. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 4, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 4, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 3, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 29, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 29, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 29, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |